Skip to main content

Current Therapeutic Research

  • ISSN: 0011-393X

Editor-In-Chief: Tsegaye

Next planned ship date: June 13, 2024

  • 5 Year impact factor: 2
  • Impact factor: 1.9

Current Therapeutic Research (CTR) is a multidisciplinary, peer-reviewed Open Access journal focusing on the discovery, development, and use of therapeutics and interven… Read more

Subscription options

Next planned ship date:
June 13, 2024

Institutional subscription on ScienceDirect

Request a sales quote
Current Therapeutic Research (CTR) is a multidisciplinary, peer-reviewed Open Access journal focusing on the discovery, development, and use of therapeutics and interventions across all therapeutic areas and all aspects of therapy. It is read by a large international audience of scientists and healthcare professionals in various research, academic, and clinical practice settings. Articles published in CTR are indexed by all major biomedical abstracting databases (e.g., PubMed/Medline, Clarivate, Scopus).

CTR aims to publish high-quality, rigorous, and ethically sound original research, be it positive, confirmatory, or negative data, with the goal of improving healthcare. The journal welcomes in-depth review articles, meta-analyses, commentaries, brief reports, case reports, research letters, and letters to the editor.

CTR promotes collaborative and interdisciplinary work with objectivity, criticism, creativity, innovation, and respect for cultural and professional diversity. By doing so, the journal provides a communication space for all therapists, regardless of their discipline or specialty.

CTR areas of interest:

Experimental medicine and therapeutics, translational medicine, clinical use of medicines and safe medication prescribing.

Topics related to new or existing drug pharmacology, such as pharmacotherapy, pharmacovigilance, pharmacoeconomics, pharmacoepidemiology, personalized medicine and ethnopharmacology.

Pharmaceutical topics including clinical trials, medicinal chemistry, drug disposition and effects, pharmaceutical medicine, pharmacodynamics, pharmacokinetics and toxicology.

Pharmacometrics: PK/PD modeling, PBPK modeling, clinical trial modeling and simulation.

Complementary medicine and therapies topics, including natural or herbal medicines that complement or replace conventional therapies - biological mechanisms of action, efficacy, safety, costs, patterns of use and implementation.

Studies relating to stem-cell and nutritional therapy, diagnostics and diagnosis, public health, quality of life, patient care, management, and education are also encouraged.

Interventions focused on all aspects of clinical therapy, including non-pharmacological ones.

Emphasis will be placed on studies of specific topics such as pediatric clinical trials and pediatric and maternal-fetal pharmacology and toxicology.

Research may involve preclinical and clinical studies and utilize both in vitro and in vivo approaches.

Please note that the journal does not publish research on traditional medicines (e.g., traditional Chinese medicine, Kampo medicine, a Japanese traditional medicine) or studies involving crude natural products.

Finally, CTR promotes inclusion and diversity by considering submissions from all over the world, whether they relate to an international or a country-specific audience (e.g., a specific patient population).

Submit your manuscript at https://www.editorialmanager.com/curtherres.